Philip Needleman
Philip Needleman (February 10, 1939 – March 25, 2024) was an American medical researcher, pharmaceutical industry executive and leader and philanthropist.
≈ 6 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Philip Needleman (February 10, 1939 – March 25, 2024) was an American medical researcher, pharmaceutical industry executive and leader and philanthropist. Needleman was a professor in and Chairman of the Department of Pharmacology, Washington University School of Medicine in St Louis, as well as former chief scientist and head of R&D at Monsanto/Searle/Pharmacia.
He was a member of the National Academy of Sciences and Institute of Medicine and served as interim president of the Donald Danforth Plant Science Center and interim CEO of the Saint Louis Science Center. He is credited with discovering the first angiotensin receptor antagonist (hypertension); discovering the first pass drug metabolism (nitroglycerin); discovering a new endocrine hormone system ANF (atriopeptin), a critical hormone that controls salt, water metabolism, blood pressure and cardiac performance (heart failure); and discovering the existence and critical role of COX-2 in inflammation and oncology.
In the pharmaceutical industry, he discovered and developed widely used therapeutics in arthritis (COX-2 inhibitors: Celebrex®, Bextra®, Parecoxib), heart failure (Eplerenone), and oncology (Sutent®).
Early life and education
Needleman was born in Brooklyn, the son of Jewish immigrants from Hungary, Louis Needleman and Lillian (née Seligman) Needleman, whose family came to the U.S. to escape pogroms in Belarus. He and his brothers attended kindergarten through eighth grade in a Yeshiva in Jersey City and moved to North Bergen in 1948.
Needleman started his public education in Horace Mann Junior High and graduated from Weehawken High School. Needleman received his Bachelor of Science degree in pharmacy in 1960 and his Master of Science in pharmacology in 1962 from the University of the Sciences. He completed his Ph.D. in Pharmacology at the University of Maryland School of Medicine in 1964.
Immediately thereafter, he joined Washington University School of Medicine as a postdoctoral fellow in the Department of Pharmacology, working with Ed Hunter, Ph.D., and Oliver H. Lowry, M.D., Ph.D.
Awards and honors
Needleman was elected to the National Academy of Sciences in 1987 in the physiology and pharmacology section and to the academy's Institute of Medicine in 1993. He received the NAS Award for the Industrial Application of Science in 2005 for his work on "metabolism of arachidonic acid in physiology and pathophysiology, which generates prostacyclin and thromboxane."
In 1994, Dr. Needleman was awarded an honorary doctorate in science from the Philadelphia College of Pharmacy and Science. He is a five-time recipient of Washington University's Distinguished Faculty Award on Founders Day and has also received the Second Century Award (1994) and an honorary doctorate in science (1999).
Philip and Sima Needleman received the Eliot Search Award in 2011 and the Robert S. Brookings Award in 20191. Needleman received numerous honors and awards including the John Jacob Abel Award of the American Pharmacology Society (1974), Research Achievement Award from the American Heart Association (1988), C. Chester Stock Award Lectureship at Memorial-Sloan Kettering Cancer Center (2001), and the Industrial Research Institute Medal (2001).
In 2002, he was appointed special advisor to the president for Research and Development at Ben-Gurion University of the Negev and had joined the university's advisory committee for the creation of a National Institute for Biotechnology in the Negev. In 2004, he received the Pharmacia-ASPET Award in Experimental Therapeutics and the Donald Danforth Plant Science Center Distinguished Service Award in 2011.
He was later named a fellow of the American Academy of Arts and Sciences in 2015.
Philanthropy
Needleman attributed his generosity to his desire to leave the world a better place, which served as his motivation to get into science. He and his wife Sima supported causes they felt would have the greatest impact, primarily through science. During the last several years, he was the architect and funder of three centers at Washington University School of Medicine in St. Louis.
The Philip and Sima Needleman Center for Autophagy Therapeutics and Research and the Philip and Sima Needleman Center for Neurometabolic and Axonal Therapeutics were established in 2019 when Philip and Sima committed $15 million to two newly created centers at Washington University School of Medicine. The centers are dedicated to advancing promising areas of research into chronic diseases of aging.
The Needlemans donated $15 million in 2023 to launch the Needleman Program in Innovation and Commercialization. The program aims to advance promising drug development into early clinical trials and help the university attract and retain exceptional faculty. Dr. Needleman had a long friendship with Dr. William Danforth, the founder of the Donald Danforth Plant Science Center.
He was a long-serving member of the Danforth Center board and had served as the Center’s interim president for over a year. In addition, to their annual giving, Philip and Sima Needleman made a significant gift in honor of Bill Danforth’s 90th birthday in 2016 and made the founding gift for the Center’s new Subterranean Influences on Nitrogen and Carbon (SINC) Center of Excellence in 2021.
The SINC Center aims to develop technologies to decrease the use of nitrogen fertilizer, a major contributor to greenhouse gas emissions. Needleman was also a supporter of several other notable institutions.
Over the years, Needleman was a major supporter to the National Academy of Sciences, National Academy of Engineering Fund, National Academy of Medicine, and the Ben-Gurion University of the Negev, where he helped to create the National Institute for Biotechnology in the Negev, Israel. In 2016, Philip and Sima Needleman endowed the Philip and Sima K. Needleman Endowed Doctoral Fellowship in Plant Conservation Genetics to the Missouri Botanical Garden to support training of a St. Louis University doctoral student working in the field of plant conservation genetics.
Dr. and Mrs. Philip Needleman generously have given to the Saint Louis Symphony Orchestra, sponsoring performances, as well as supported the Jewish Federation of St Louis and been major supporters of the Saint Louis Science Center and their Youth Exploring Science (YES) Program, which celebrated its 20th anniversary in 2019.
Personal life
Needleman died on March 25, 2024 when a 100-foot tree came crashing down on him while he was walking in the woods with his dog. He was survived by his wife of 68 years, Sima Kolman Needleman, their two children, and their two grandchildren.
External links
National Academy of Sciences profile Obituary
Text derived from https://en.wikipedia.org/w/index.php?oldid=1378137222 under CC BY-SA 4.0; modifications have been made.
References
1 claim could not be tied to a specific sentence and is listed in the table below instead.
- ↩Wikipedia “Philip Needleman” date of establishment (×1) · confidence 0.95 revision URL